Elevance Health ROE 2010-2024 | ELV
Current and historical return on equity (ROE) values for Elevance Health (ELV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Elevance Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-09-30 | $6.42B | $43.88B | 15.44% |
| 2024-06-30 | $6.69B | $42.30B | 16.63% |
| 2024-03-31 | $6.24B | $40.71B | 15.91% |
| 2023-12-31 | $5.99B | $39.41B | 15.58% |
| 2023-09-30 | $6.00B | $38.54B | 15.92% |
| 2023-06-30 | $6.31B | $38.31B | 17.04% |
| 2023-03-31 | $6.09B | $37.46B | 16.73% |
| 2022-12-31 | $5.89B | $36.33B | 16.34% |
| 2022-09-30 | $6.22B | $36.04B | 17.27% |
| 2022-06-30 | $6.13B | $35.87B | 17.04% |
| 2022-03-31 | $6.28B | $36.03B | 17.57% |
| 2021-12-31 | $6.16B | $36.13B | 17.48% |
| 2021-09-30 | $5.52B | $35.81B | 16.00% |
| 2021-06-30 | $4.23B | $35.05B | 12.44% |
| 2021-03-31 | $4.71B | $33.92B | 13.92% |
| 2020-12-31 | $4.57B | $33.20B | 13.72% |
| 2020-09-30 | $4.96B | $33.92B | 15.04% |
| 2020-06-30 | $5.92B | $34.46B | 18.31% |
| 2020-03-31 | $4.78B | $31.69B | 15.23% |
| 2019-12-31 | $4.81B | $31.73B | 15.53% |
| 2019-09-30 | $4.30B | $31.33B | 14.24% |
| 2019-06-30 | $4.07B | $30.79B | 13.76% |
| 2019-03-31 | $3.99B | $30.00B | 13.71% |
| 2018-12-31 | $3.75B | $28.54B | 13.23% |
| 2018-09-30 | $4.56B | $29.09B | 16.37% |
| 2018-06-30 | $4.34B | $28.73B | 16.06% |
| 2018-03-31 | $4.15B | $27.01B | 15.66% |
| 2017-12-31 | $3.84B | $26.50B | 14.64% |
| 2017-09-30 | $2.98B | $25.95B | 11.51% |
| 2017-06-30 | $2.85B | $26.43B | 11.14% |
| 2017-03-31 | $2.78B | $26.09B | 11.09% |
| 2016-12-31 | $2.47B | $25.10B | 10.12% |
| 2016-09-30 | $2.28B | $24.74B | 9.56% |
| 2016-06-30 | $2.32B | $24.23B | 9.87% |
| 2016-03-31 | $2.40B | $23.55B | 10.33% |
| 2015-12-31 | $2.56B | $23.04B | 10.93% |
| 2015-09-30 | $2.89B | $23.24B | 12.17% |
| 2015-06-30 | $2.86B | $23.06B | 11.93% |
| 2015-03-31 | $2.73B | $24.33B | 11.24% |
| 2014-12-31 | $2.57B | $24.25B | 10.57% |
| 2014-09-30 | $2.21B | $24.29B | 9.04% |
| 2014-06-30 | $2.24B | $24.38B | 9.10% |
| 2014-03-31 | $2.31B | $24.35B | 9.37% |
| 2013-12-31 | $2.49B | $24.77B | 10.12% |
| 2013-09-30 | $2.81B | $24.81B | 11.51% |
| 2013-06-30 | $2.84B | $24.53B | 11.78% |
| 2013-03-31 | $2.68B | $24.32B | 11.23% |
| 2012-12-31 | $2.66B | $23.80B | 11.21% |
| 2012-09-30 | $2.53B | $23.82B | 10.72% |
| 2012-06-30 | $2.52B | $23.64B | 10.70% |
| 2012-03-31 | $2.58B | $23.53B | 10.88% |
| 2011-12-31 | $2.65B | $23.29B | 11.13% |
| 2011-09-30 | $2.86B | $23.72B | 11.96% |
| 2011-06-30 | $2.92B | $24.18B | 12.11% |
| 2011-03-31 | $2.94B | $23.98B | 12.24% |
| 2010-12-31 | $2.89B | $23.81B | 11.97% |
| 2010-09-30 | $5.08B | $24.36B | 20.83% |
| 2010-06-30 | $5.07B | $23.79B | 21.12% |
| 2010-03-31 | $5.04B | $24.52B | 21.35% |
| 2009-12-31 | $4.75B | $24.86B | 20.75% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $84.995B | $171.340B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| ICON (ICLR) | Ireland | $16.879B | 15.03 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| Revvity (RVTY) | United States | $13.453B | 23.37 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |